Remdesivir and molnupiravir had comparable efficacy in lung transplant recipients with mild-to-moderate COVID-19: a single center experience
Razia et al., Frontiers in Transplantation, doi:10.3389/frtra.2024.1408289
https://c19early.org/razia.html